"As an internationally renowned authority on radiosurgery, we expect Dr. Larson's expertise and insights about technology trends and clinical practice in our industry to contribute significantly to our growth. Mert Ozyurek's years of directly relevant experience in developing the potentially enormous Turkish market for the Gamma Knife will help us accelerate our international expansion initiatives. We are enormously pleased to welcome Dr. Larson and Mr. Ozyurek to our Board," said AMS Chairman and Chief Executive Officer Ernest A. Bates, M.D. "We also want to thank Olin Robison for his many contributions to AMS over the years, and wish him continued success."About AMS American Shared Hospital Services ( www.ashs.com) provides turnkey technology solutions for advanced radiosurgical and radiation therapy services. Since 1991, AMS' creative financing solutions have enabled its clinical partners to make the latest advances in radiation oncology available to patients at an affordable price. AMS is the world leader in providing Gamma Knife® Radiosurgery equipment, a non-invasive treatment for malignant and benign brain tumors, vascular malformations and trigeminal neuralgia (facial pain). The Company also offers the latest IGRT and IMRT systems, as well as its proprietary Operating Room for the 21st Century® concept. AMS also is a leader in proton beam radiation therapy (PBRT), the next great growth opportunity in radiation oncology. AMS currently is developing PBRT centers in Dayton, Ohio (Kettering Medical Center), Boston (Tufts Medical Center), Orlando (Orlando Regional Healthcare) and Long Beach, California (Long Beach Memorial Medical Center), and is negotiating additional projects. AMS also owns a preferred stock investment in Still River Systems, developer of the compact Monarch 250 PBRT system, which has not yet been approved by the FDA. Safe Harbor Statement This press release may be deemed to contain certain forward-looking statements with respect to the financial condition, results of operations and future plans of American Shared Hospital Services, which involve risks and uncertainties including, but not limited to, the risks of the Gamma Knife and radiation therapy businesses, the risks of developing The Operating Room for the 21st Century program, and the risks of investing in a development-stage company, Still River Systems, Inc., without a proven product. Further information on potential factors that could affect the financial condition, results of operations and future plans of American Shared Hospital Services is included in the filings of the Company with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K for the year ended December 31, 2010, the Quarterly Report on Form 10-Q for the quarter ended March 31, 2011, and the definitive Proxy Statement for the Annual Meeting of Shareholders held on June 9, 2011.
AMERICAN SHARED HOSPITAL SERVICES (NYSE AMEX:AMS), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced the election of Dr. David A. Larson and S. Mert Ozyurek to its Board of Directors at the Company's Annual Meeting held on June 9, 2011. With the retirement from the Board of Olin C. Robison, a director since 2003, these two new directors increase AMS' Board to six members, including five outside directors. David A. Larson, M.D., Ph.D., 70 years old, is an internationally recognized authority on brain tumors and central nervous system and body radiosurgery, intensity modified radiotherapy, and highly conformal radiotherapy. He holds a Ph.D. in high energy physics from the University of Chicago and an M.D. from the University of Miami School of Medicine. He completed his medical internship at the University of California, San Francisco, and his radiation oncology residency training at Harvard Medical School, where he also served as attending physician and instructor. Dr. Larson has been a member of the UCSF faculty since 1986, leading to joint professorial appointments in the Departments of Radiation Oncology and Neurosurgery. He served as president of the American Society for Therapeutic Radiology and Oncology, the Northern California Radiation Oncology Society, and the International Stereotactic Radiosurgery Society, and has been recognized as one of America's top doctors every year since 1991. S. Mert Ozyurek, 36 years old, is currently the President of Ozyurek A.S., the preferred supplier of Elekta Gamma Knife systems to hospitals in Turkey, and EMKA, LLC, an affiliate of Ozyurek A.S. in the United States. Prior to that, he served as Vice President in Ozyurek A.S., overseeing international business and business development. He joined Ozyurek A.S. after serving in the Turkish Air Force. Mr. Ozyurek is a partner in the subsidiary that AMS has developed for its future operations in Turkey. He received a B.A. degree from Middle East Technical University in Ankara, Turkey.